A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis
Status:
Completed
Trial end date:
2018-04-11
Target enrollment:
Participant gender:
Summary
This research is being done to determine if Nitazoxanide (NTZ) will cause a significant
decrease in the number of M. tuberculosis bacteria in sputum after 14 days of treatment. The
study is being conducted at the GHESKIO Centers in Port au Prince Haiti